Inflammatory Arthritis, Machine Learning and Digital Technologies: the future of diagnosis and management
The diagnosis and management of rheumatic diseases has evolved considerably over the last 2 decades. We are also witnessing a rapid progress of new technological advances in healthcare. The development and validation of new technologies in rheumatic disease provides an exciting opportunity to evolve and optimise personalised care for your patients in the 21st century. This talk will describe current rheumatology practice and explore opportunities to develop new technologies in the field.
Dr Raj Sengupta is a Consultant Rheumatologist and Lead for Ankylosing Spondylitis at The Royal National Hospital for Rheumatic Diseases, Bath (RNRHD). He is a member of the BSR Spondyloarthritis Special Interest Group, the BSR AxSpA Biologics Guidelines Committee and a member of ASAS (Assessment of Spondyloarthritis International Society).
He has represented the BSR at the NICE TA383 appraisal for anti TNF in AxSpA. Dr Sengupta is a trustee and medical advisor for the National Ankylosing Spondylitis Society (NASS) and is one of the founder members of BRITSpA. Dr Sengupta was the recipient of the 2016 NASS Patients Choice award for the Best care provided by a Rheumatologist.
He is the principal investigator in several national and international clinical trials in Axial Spondylarthritis. He has a number of peer reviewed publications on AxSpA. Dr Sengupta has been an invited speaker on AxSpA at several national and international meetings.
You can register for tickets here:
This event will have a waiting list, so please remember to cancel your ticket if you become unable to attend.